How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?
Our model estimates second-quarter 2025 sales for the overall neuroscience franchise to be $2.5 billion, representing around 15% year-over-year growth. Higher sales of Botox Therapeutic and Vraylar are likely to have contributed to growth during the quarter. Sales of Ubrelvy and Qulipta might have benefited from market share gains across their respective approved indications.
While Vyalev was recently launched in the United States and is expected to have delivered modest domestic revenues in the second quarter, the drug is already approved in several international markets. As such, a majority of Vyalev's second-quarter sales are likely to have come from ex-U.S. regions.
Though AbbVie's neuroscience portfolio continues to grow meaningfully, investor focus will largely remain on its immunology franchise, which houses three flagship drugs — Humira, Rinvoq and Skyrizi. All eyes will be on the magnitude of their sequential growth and market share gains when the company reports second-quarter results on July 31.
Competition in the Neuroscience Space
Other bigger players in this space are Biogen BIIB and Johnson & Johnson JNJ.
Despite the steeply declining revenues of its multiple sclerosis franchise, Biogen generates more than half of its top line from neuroscience therapies. BIIB is one of the handful of companies that markets an FDA-approved treatment for Alzheimer's disease (AD), Leqembi, in partnership with Eisai. Biogen also markets Zurzuvae, the first and only FDA-approved oral treatment for postpartum depression (PPD).
While not competing with Biogen directly in the neuroscience space, AbbVie is actively developing AD therapies as part of its neuroscience expansion strategy.
J&J markets several leading neuroscience products, led by the blockbuster antidepressant nasal spray Spravato and antipsychotic drug Invega Sustenna. Both remain key growth drivers for the company's pharma unit. In April, J&J closed the acquisition of Intra-Cellular Therapies, which added antidepressant drug Caplyta to its neuroscience portfolio. While already approved for schizophrenia and bipolar depression, a regulatory filing is under FDA review for the drug in a third indication — major depressive disorder — with a regulatory decision expected later this year.
ABBV's Price Performance, Valuation and Estimates
Shares of AbbVie have outperformed the industry year to date, as shown in the chart below.
From a valuation standpoint, AbbVie is not very cheap. Based on the price/earnings (P/E) ratio, the company's shares currently trade at 14.06 times forward earnings, a tad lower than its industry's average of 14.60. The stock is cheaper than some other large drugmakers, such as Eli Lilly and Novo Nordisk, but priced much higher than most other large drugmakers. The stock is currently trading above its five-year mean of 12.55.
While the EPS estimates for 2025 have declined from $12.32 to $11.98, the same for 2026 have increased from $14.06 to $14.08 over the past 30 days.
AbbVie currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Free: See Our Top Stock And 4 Runners Up
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Biogen Inc. (BIIB): Free Stock Analysis Report
Johnson & Johnson (JNJ): Free Stock Analysis Report
AbbVie Inc. (ABBV): Free Stock Analysis Report
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Sidus Space Announces Pricing of Public Offering
Sidus Space, Inc. (Nasdaq: SIDU) ("Sidus" or the "Company"), an innovative, agile space and defense technology company providing flexible, cost-effective solutions to government, defense, intelligence, and commercial companies around the globe, today announced the pricing of a best-efforts public offering of 7,143,000 shares of its Class A common stock. Each share of Class A common stock is being sold at a public offering price of $1.05 per share for gross proceeds of approximately $7.5 million, before deducting the placement agent's fees and offering expenses. All of the shares of common stock are being offered by the Company. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The offering is expected to close on July 29, 2025, subject to customary closing conditions. ThinkEquity is acting as sole placement agent for the offering. The securities will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-273430), including a base prospectus, filed with the U.S. Securities and Exchange Commission (the 'SEC') on July 26, 2023 and declared effective on August 14, 2023. The offering will be made only by means of a written prospectus. A preliminary prospectus supplement and accompanying prospectus describing the terms of the offering has been filed with the SEC on its website at A final prospectus supplement and accompanying prospectus related to the offering will be filed with the SEC and made available on the SEC's website. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained, when available, from the offices of ThinkEquity, 17 State Street, 41 st Floor, New York, New York 10004. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Sidus Space Sidus Space (NASDAQ: SIDU) is an innovative, agile space and defense technology company offering flexible, cost-effective solutions, including satellite manufacturing and technology integration, AI-driven space-based data solutions, mission planning and management operations, AI/ML products and services, and space and defense hardware manufacturing. With its mission of Space Access Reimagined®, Sidus Space is committed to rapid innovation, adaptable and cost-effective solutions, and the optimization of space system and data collection performance. With demonstrated space heritage, including manufacturing and operating its own satellite and sensor system, LizzieSat®, Sidus Space serves government, defense, intelligence, and commercial companies around the globe. Strategically headquartered on Florida's Space Coast, Sidus Space operates a 35,000-square-foot space manufacturing, assembly, integration, and testing facility and provides easy access to nearby launch facilities. For more information, visit: Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements' within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and other factors described more fully in the section entitled 'Risk Factors' in Sidus Space's prospectus supplement and Annual Report on Form 10-K for the year ended December 31, 2024, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Sidus Space, Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.
Globe and Mail
2 hours ago
- Globe and Mail
U.S. and European Union reach trade pact that sets 15-per-cent tariff on EU goods
The United States struck a framework trade deal with the European Union Sunday that imposes a 15-per-cent U.S. import tariff on most EU goods, including autos, and leaves 50-per-cent levies on steel and aluminum shipments from the continent. The announcement came after European Commission President Ursula von der Leyen travelled to western Scotland for talks with U.S. President Donald Trump at his golf course there. Ms. von der Leyen said the agreed-upon 15-per-cent tariff applies 'across the board' to U.S.-bound shipments from the EU. The deal, while short on details, also includes a commitment by the EU to make US$600-billion of investments in the United States, and to make significant purchases of U.S. energy and military equipment. 'It's a huge deal. It will bring stability. It will bring predictability,' she said. The Editorial Board: Trump's tariff shakedown takes shape The agreement largely mirrors a framework deal that the U.S. clinched with Japan last week, where Japanese automobiles will face a 15-per-cent U.S. tariff but U.S. steel and aluminum levies of 50 per cent remain in place. And it arrives at a critical moment in Canada's own trade negotiations with the Trump administration. Prime Minister Mark Carney faces an Aug. 1 deadline to strike a deal before the White House raises an existing tariff on Canadian goods. Mr. Carney and Mr. Trump have both signalled that a deal by the beginning of next month may not happen, with Mr. Carney saying he will accept only the best deal for Canada. On the U.S.-EU deal, Mr. Trump said: 'We are agreeing that the tariff ... for automobiles and everything else will be a straight across tariff of 15 per cent. Steel is staying the way it is – that's a worldwide thing,' the U.S. President said of his tariffs on foreign steel. Mr. Trump, who is seeking to reorder the global economy and reduce decades-old U.S. trade deficits with trading partners, has so far also signed agreements with Britain, Indonesia and Vietnam. By comparison, the trade deal the President struck with Britain in May would see British cars subject to a 10-per-cent tariff up to 100,000 vehicles and on shipments above, a 25-per-cent rate. Mr. Trump talked up the new agreement as 'the biggest of all the deals,' with total trade between the U.S. and the EU totalling US$976-billion in 2024, according to the Office of the U.S. Trade Representative. Given the size of this relationship, the agreement could set a precedent for future U.S. deals, including with Canada. Opinion: Canada, we've already got Trump's best trade deal Since returning to office earlier this year, Mr. Trump has hit Canada with a string of tariffs: 50 per cent on steel and aluminum; 25 per cent on autos; and 25 per cent on any goods traded outside the United States-Mexico-Canada Agreement, with the exception of oil, gas and potash, at 10 per cent. He has threatened to increase the non-USMCA tariff to 35 per cent if there is no deal by Aug. 1. William Pellerin, a partner with McMillan LLP's international trade group, said the fact that Mr. Trump doesn't appear to be cutting steel and aluminum tariffs, or agreeing to lower baseline tariffs with key trading partners, is not a good sign for Canada. The details of recent deals 'show that the tariffs are stickier than we might have anticipated, even for developed economies and close U.S. allies, which is certainly a bit of a bad omen in some ways for Canada,' Mr. Pellerin said. He said the silver lining for Canada is it 'doesn't look like anyone's going to get better market access to the United States than Canada, even if we do get stuck with a baseline tariff.' Goldy Hyder, president of the Business Council of Canada, said Canada and Mexico are in a different position from other countries. This is both because of the White House rationale for the 25-per-cent tariff on most Canadian and Mexican goods – Mr. Trump cited illegal fentanyl smuggling as one reason – and because of the exemption for products traded in compliance with the USMCA. Campbell Clark: Mark Carney faces the politics of concession Japan and the European Union did not qualify for a USMCA-style exemption and therefore had to 'buy down' tariffs with major commitments to purchase U.S. goods or make investments in the United States, he noted. Mr. Hyder said Canada needs to preserve its special access under the USMCA, which is up for renegotiation in 2026, or possibly sooner. 'Our goal has to be keeping the exemption, and that means preserving and extending the USMCA must be our top priority.' There are some significant trade differences between Canada and the EU – and they work in Canada's favour. For one, Canada is the top destination for U.S. goods exports, according to the USTR, bringing in US$349-billion worth of American goods in 2024. Canada also has a much smaller trade surplus with the U.S. than the EU. Mr. Trump has taken particular issue with such imbalances, which he considers unfair − even when they benefit American consumers. Canada also has an intricately linked supply chain with the U.S. in multiple industries, including automobiles and energy, with many products shipped back and forth across the Canada-U.S. border many times before they are sold to end users. The two countries also have an existing trade agreement, the USMCA, which Mr. Trump negotiated during his first term. Throughout months of talks, European officials threatened reciprocal tariffs on the U.S. and prepared a retaliatory package of tariffs of up to 30 per cent against €92-billion worth of U.S. exports. In the end, however, the EU will not retaliate, despite now facing 15-per-cent tariffs across most goods. Explaining her rationale, the EU's Ms. von der Leyen told reporters that the deal will bring 'stability' and 'predictability.' Yet many key elements of the trade relationship between the U.S. and the EU remain uncertain. For now, Mr. Trump is maintaining his 50-per-cent tariff on steel. And while pharmaceuticals will initially fall under Sunday's 15-per-cent agreement, that is subject to change. More details are also needed on the purchase and investment promises. The EU agreed to purchase US$750-billion worth of American energy products and to also invest US$600-billion in the United States on top of existing expenditures, but it is not clear who will make these investments or how they will be enforced. A similar investment agreement was made by Japan when it announced its own trade deal with the U.S. last week. But within days, Japanese officials started pouring cold water on some of the terms. Mr. Trump had claimed that the U.S. would make 90 per cent of profits on Japanese investments into the U.S., but Japan later pushed back and said its understanding was that profits would be based on the contribution made, and the risk taken, by each party. Tony Keller: As Trump's tariff walls rise, Canada's negotiating leverage is shrinking While Mr. Trump remains far from his initial goal of signing 90 trade deals in 90 days, stock-market investors have been reassured that agreements with major developed countries and regions are finally coming in and that the 15-per-cent tariff rates with major economies are lower than the levels Mr. Trump had threatened during the negotiations. However, 15-per-cent tariffs are much higher than the equivalent rates at the start of the year, and it isn't clear yet who will absorb them − companies or American consumers − because so far, price increases have been muted after companies piled up inventory early in the year. There are signs, however, that some pain is coming − particularly in sectors that Mr. Trump has singled out, including automobiles and steel. Volkswagen reported earnings on Friday and said tariffs cost the company €1.3-billion over the first six months of the year, and that going forward, the German car maker is lowering its operating profit to a range of 4 per cent to 5 per cent for 2025, down from 5.5 per cent to 6.5 per cent.
National Post
7 hours ago
- National Post
Trump and EU strike deal for 15 per cent tariffs on most goods, avoiding trade war
The United States and the European Union agreed on Sunday to a trade framework setting a 15 per cent tariff on most goods, staving off — at least for now — far higher imports on both sides that might have sent shockwaves through economies around the globe. Article content The sweeping announcement came after President Donald Trump and European Commission chief Ursula von der Leyen met briefly at Trump's Turnberry golf course in Scotland. Their private sit-down culminated months of bargaining, with the White House deadline Friday nearing for imposing punishing tariffs on the EU's 27-member countries. Article content Article content 'It was a very interesting negotiation. I think it's going to be great for both parties,' Trump said. The agreement, he said, was 'a good deal for everybody' and 'a giant deal with lots of countries.' Article content Article content As with other recent tariff agreements that Trump announced with countries including Japan and the United Kingdom, some major details remain pending in this one. Article content Trump said the EU had agreed to buy some $750 billion worth of U.S. energy and invest $600 billion more than it already is in America — as well as make a major military equipment purchase. He said tariffs 'for automobiles and everything else will be a straight across tariff of 15 per cent' and meant that U.S. exporters 'have the opening up of all of the European countries.' Article content Von der Leyen said the 15 per cent tariffs were 'across the board, all inclusive' and that 'indeed, basically the European market is open.' Article content Article content Article content At a later news conference away from Turnberry, she said that the $750 billion in additional U.S. energy purchases was actually over the next three years — and would help ease the dependence on natural gas from Russia among the bloc's countries. Article content 'When the European Union and the United States work together as partners, the benefits are tangible,' Von der Leyen said, noting that the agreement 'stabilized on a single, 15 per cent tariff rate for the vast majority of EU exports,' including cars, semiconductors and pharmaceuticals. Article content '15 per cent is a clear ceiling,' she said. Article content But von der Leyen also clarified that such a rate wouldn't apply to everything, saying that both sides agreed on 'zero for zero tariffs on a number of strategic products,' like all aircraft and component parts, certain chemicals, certain generic drugs, semiconductor equipment, some agricultural products, natural resources and critical raw materials.
